Summary
This narrative review synthesises current understanding of polycystic ovary syndrome as a multifactorial endocrine disorder, with particular emphasis on insulin resistance and elevated androgen levels as primary aetiological drivers. The authors argue that clarifying the mechanistic interplay between these two pathways is essential for developing targeted nutritional and therapeutic interventions, and note that further research is required to fully elucidate their mutual contributions to disease development and progression.
UK applicability
The pathophysiological mechanisms described are relevant to PCOS management across UK clinical practice and may inform dietary and lifestyle advice delivered through NHS services and primary care. However, the abstract does not specify whether evidence synthesis reflects UK-specific epidemiology or treatment guidelines.
Key measures
Patterns of insulin resistance, androgen levels, and their combined effects on PCOS pathophysiology and symptom heterogeneity
Outcomes reported
The study examined the pathophysiological mechanisms linking insulin resistance (IR) and hyperandrogenemia (HA) to polycystic ovary syndrome (PCOS) development and symptom severity. The authors reviewed how understanding these dual pathways could inform nutritional, lifestyle and pharmacological interventions for PCOS management.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.